Module 5 – Progression, Flare, or Toxicity? Differentiating Mid-Treatment Skin Changes

New or changing skin findings during cutaneous T-cell lymphoma (CTCL) therapy can reflect disease progression, a treatment-related eruption, or an infection, and distinguishing among these possibilities is essential to avoid either premature discontinuation of an effective therapy or delayed…

Price

Free

Accredited provider:

i3 Health

Learning platform:

IQ Apparatus

Release date

August 27, 2026

Expires

August 26, 2027